These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9815574)
21. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells. Grandinetti KB; Spengler BA; Biedler JL; Ross RA Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Krajewski S; Chatten J; Hanada M; Reed JC Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790 [TBL] [Abstract][Full Text] [Related]
23. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907 [TBL] [Abstract][Full Text] [Related]
24. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma. Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885 [TBL] [Abstract][Full Text] [Related]
25. GAP-43 mRNA in growth cones is associated with HuD and ribosomes. Smith CL; Afroz R; Bassell GJ; Furneaux HM; Perrone-Bizzozero NI; Burry RW J Neurobiol; 2004 Nov; 61(2):222-35. PubMed ID: 15389607 [TBL] [Abstract][Full Text] [Related]
26. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914 [TBL] [Abstract][Full Text] [Related]
27. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related]
28. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748 [TBL] [Abstract][Full Text] [Related]
29. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly. Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552 [TBL] [Abstract][Full Text] [Related]
30. [Cloning, expression and purification of neural specific HuD cDNA]. Chen JH; Liu XQ; Guo YP; Zhang B; Zhou Y; Hu XY; Yuan JG; Qiang BQ; Peng XZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):250-3. PubMed ID: 12905628 [TBL] [Abstract][Full Text] [Related]
31. TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD. Saito K; Fujiwara T; Katahira J; Inoue K; Sakamoto H Biochem Biophys Res Commun; 2004 Aug; 321(2):291-7. PubMed ID: 15358174 [TBL] [Abstract][Full Text] [Related]
32. A role for the ELAV RNA-binding proteins in neural stem cells: stabilization of Msi1 mRNA. Ratti A; Fallini C; Cova L; Fantozzi R; Calzarossa C; Zennaro E; Pascale A; Quattrone A; Silani V J Cell Sci; 2006 Apr; 119(Pt 7):1442-52. PubMed ID: 16554442 [TBL] [Abstract][Full Text] [Related]
33. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503 [TBL] [Abstract][Full Text] [Related]
34. Hu neuronal proteins are expressed in proliferating neurogenic cells. Marusich MF; Furneaux HM; Henion PD; Weston JA J Neurobiol; 1994 Feb; 25(2):143-55. PubMed ID: 7517436 [TBL] [Abstract][Full Text] [Related]
35. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas. Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911 [TBL] [Abstract][Full Text] [Related]
36. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152 [TBL] [Abstract][Full Text] [Related]
37. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors. Wachowiak R; Fiegel HC; Kaifi JT; Quaas A; Krickhahn A; Schurr PG; Erttmann R; Schachner M; Kluth D; Sauter G; Izbicki JR Ann Surg Oncol; 2007 Dec; 14(12):3575-80. PubMed ID: 17917782 [TBL] [Abstract][Full Text] [Related]
38. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma. Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322 [TBL] [Abstract][Full Text] [Related]
39. CK20 gene expression: technical limits for the detection of circulating tumor cells. Champelovier P; Mongelard F; Seigneurin D Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150 [TBL] [Abstract][Full Text] [Related]
40. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]